Purpose The advanced lung cancer inflammation index (ALI) is a useful tool to predict the
clinical outcome in several malignancies. The ALI not only contains indices related to …

Introduction Systemic inflammation is associated with prognosis in solid tumors. The
neutrophil-to-lymphocyte ratio (NLR) is a marker for the general immune response to various …

Simple Summary Predictive markers are necessary for immune checkpoint inhibitor (ICI)
therapy. The aim of our retrospective study was to investigate the relationship between the …

High-dose interferon alfa-2b (IFN-α-2b) improves the survival of patients with high-risk
melanoma. We aimed to identify baseline peripheral blood biomarkers to predict the …

Introduction Cutaneous malignant melanoma (CMM) incidence has risen rapidly in the last
50 years. Poor progression and high mortality characterize CMM, making a thorough …

Background Myeloid-derived suppressor cells (MDSC), a cornerstone of cancer-related
immunosuppression, influence response to therapy and disease outcomes in melanoma …

Background: The neutrophil-to-lymphocyte ratio (NLR) is an independent prognostic marker
in solid and hematological cancers. While the derived NLR (dNLR) was shown to be non …

Background: Inflammation is critical to the pathogenesis and progression of cancer, with a
high neutrophil–lymphocyte ratio (NLR) associated with poor prognosis. The utility of …

Background Hematologic markers, such as the neutrophil‐to‐lymphocyte ratio (NLR),
characterize the inflammatory response to cancer and are associated with poorer survival in …

Skin cancer affects more individuals in the USA than any other malignancy and malignant
melanoma is particularly deadly because of its metastatic potential. Melanoma has been …